472 related articles for article (PubMed ID: 25511680)
1. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
2. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
[TBL] [Abstract][Full Text] [Related]
3. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
Alonso R; López-Guerra M; Upshaw R; Bantia S; Smal C; Bontemps F; Manz C; Mehrling T; Villamor N; Campo E; Montserrat E; Colomer D
Blood; 2009 Aug; 114(8):1563-75. PubMed ID: 19541822
[TBL] [Abstract][Full Text] [Related]
4. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
Sampath D; Calin GA; Puduvalli VK; Gopisetty G; Taccioli C; Liu CG; Ewald B; Liu C; Keating MJ; Plunkett W
Blood; 2009 Apr; 113(16):3744-53. PubMed ID: 19096009
[TBL] [Abstract][Full Text] [Related]
5. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
7. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
Tonino SH; van Laar J; van Oers MH; Wang JY; Eldering E; Kater AP
Oncogene; 2011 Feb; 30(6):701-13. PubMed ID: 20935673
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
[TBL] [Abstract][Full Text] [Related]
9. c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
Hallaert DY; Jaspers A; van Noesel CJ; van Oers MH; Kater AP; Eldering E
Blood; 2008 Dec; 112(13):5141-9. PubMed ID: 18796631
[TBL] [Abstract][Full Text] [Related]
10. TAp73-mediated the activation of c-Jun N-terminal kinase enhances cellular chemosensitivity to cisplatin in ovarian cancer cells.
Zhang P; Liu SS; Ngan HY
PLoS One; 2012; 7(8):e42985. PubMed ID: 22900074
[TBL] [Abstract][Full Text] [Related]
11. P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.
Al-Bahlani S; Fraser M; Wong AY; Sayan BS; Bergeron R; Melino G; Tsang BK
Oncogene; 2011 Oct; 30(41):4219-30. PubMed ID: 21516125
[TBL] [Abstract][Full Text] [Related]
12. PLK2 phosphorylates and inhibits enriched TAp73 in human osteosarcoma cells.
Hu ZB; Liao XH; Xu ZY; Yang X; Dong C; Jin AM; Lu H
Cancer Med; 2016 Jan; 5(1):74-87. PubMed ID: 26625870
[TBL] [Abstract][Full Text] [Related]
13. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2.
Taebunpakul P; Sayan BS; Flinterman M; Klanrit P; Gäken J; Odell EW; Melino G; Tavassoli M
Apoptosis; 2012 Aug; 17(8):762-76. PubMed ID: 22484480
[TBL] [Abstract][Full Text] [Related]
14. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
15. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
[TBL] [Abstract][Full Text] [Related]
16. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
Mackus WJ; Kater AP; Grummels A; Evers LM; Hooijbrink B; Kramer MH; Castro JE; Kipps TJ; van Lier RA; van Oers MH; Eldering E
Leukemia; 2005 Mar; 19(3):427-34. PubMed ID: 15674362
[TBL] [Abstract][Full Text] [Related]
17. The potential anticancer agent PK11195 induces apoptosis irrespective of p53 and ATM status in chronic lymphocytic leukemia cells.
Santidrián AF; Cosialls AM; Coll-Mulet L; Iglesias-Serret D; de Frias M; González-Gironès DM; Campàs C; Domingo A; Pons G; Gil J
Haematologica; 2007 Dec; 92(12):1631-8. PubMed ID: 18055986
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
Song H; Wei M; Liu W; Shen S; Li J; Wang L
Histol Histopathol; 2018 Jan; 33(1):73-79. PubMed ID: 28287251
[TBL] [Abstract][Full Text] [Related]
19. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
20. N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.
Ruhul Amin AR; Thakur VS; Gupta K; Agarwal MK; Wald DN; Shin DM; Agarwal ML
Oncogene; 2013 Feb; 32(7):920-9. PubMed ID: 22430213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
